Mark Mallon

CEO & Board Member

Mr. Mallon was appointed to be the NeoGenomics Chief Executive Officer and Member of the Board of Directors, effective April 15, 2021. Mark Mallon has had a long and distinguished career in health care. Prior to serving as CEO of Ironwood Pharmaceuticals, where he led the financial transformation of the company to profitability and significantly...

Roles at NeoGenomics

  • CEO & Board Member

    April 19, 2021 - present

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.